Item 5.07 Submission of Matters to a Vote of Security Holders.

C4 Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders on June 22, 2022 (the "Annual Meeting"). The following is a summary of the matters voted on at the Annual Meeting.



   a) The stockholders of the Company elected each of Bruce Downey and Glenn Dubin
      as Class II directors, to hold office until the 2025 annual meeting of
      stockholders and until their respective successors have been duly elected
      and qualified. The results of the stockholders' vote with respect to the
      election of the Class II directors were as follows:


Name          Votes For     Votes Withheld    Broker Non-Votes
Bruce Downey 16,221,318      13,812,875         11,471,383
Glenn Dubin  18,740,397      11,293,796         11,471,383


   b) The stockholders of the Company cast a non-binding, advisory vote on the
      frequency of future non-binding, advisory votes to approve the compensation
      of the Company's named executive officers. The results of the stockholders'
      vote with respect to this proposal were as follows:


  One Year   Two Years   Three Years  Abstain    Broker Non-Votes
29,265,694     8,439      333,206     426,854           11,471,383


   c) The stockholders of the Company cast a non-binding, advisory vote to approve
      the compensation of the Company's named executive officers. The results of
      the stockholders' vote with respect to this proposal were as follows:


 Votes For     Votes Against     Abstain    Broker Non-Votes
29,207,646       262,241        564,306       11,471,383


   d) The stockholders of the Company ratified the selection of KPMG LLP as the
      Company's independent registered public accounting firm for the fiscal year
      ending December 31, 2022. The results of the stockholders' vote with respect
      to this ratification proposal were as follows:


 Votes For     Votes Against    Abstain    Broker Non-Votes
41,468,547        25,815        11,214        0

No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses